Cargando…

The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer

OBJECTIVE: To investigate the impact of digital PET/CT on diagnostic certainty, patient-based sensitivity and interrater reliability. METHODS: Four physicians retrospectively evaluated two matched cohorts of patients undergoing [(68)Ga]Ga-PSMA-11 PET/CT on a digital (dPET/CT n = 65) or an analogue s...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Ian, Hünermund, Jan-Niklas, Sachpekidis, Christos, Mingels, Clemens, Fech, Viktor, Bohn, Karl Peter, Rominger, Axel, Afshar-Oromieh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452558/
https://www.ncbi.nlm.nih.gov/pubmed/33856522
http://dx.doi.org/10.1007/s00330-021-07870-5
_version_ 1784570095939354624
author Alberts, Ian
Hünermund, Jan-Niklas
Sachpekidis, Christos
Mingels, Clemens
Fech, Viktor
Bohn, Karl Peter
Rominger, Axel
Afshar-Oromieh, Ali
author_facet Alberts, Ian
Hünermund, Jan-Niklas
Sachpekidis, Christos
Mingels, Clemens
Fech, Viktor
Bohn, Karl Peter
Rominger, Axel
Afshar-Oromieh, Ali
author_sort Alberts, Ian
collection PubMed
description OBJECTIVE: To investigate the impact of digital PET/CT on diagnostic certainty, patient-based sensitivity and interrater reliability. METHODS: Four physicians retrospectively evaluated two matched cohorts of patients undergoing [(68)Ga]Ga-PSMA-11 PET/CT on a digital (dPET/CT n = 65) or an analogue scanner (aPET/CT n = 65) for recurrent prostate cancer between 11/2018 and 03/2019. The number of equivocal and pathological lesions as well as the frequency of discrepant findings and the interrater reliability for the two scanners were compared. RESULTS: dPET/CT detected more lesions than aPET/CT (p < 0.001). A higher number of pathological scans were observed for dPET/CT (83% vs. 57%, p < 0.001). The true-positive rate at follow-up was 100% for dPET/CT compared to 84% for aPET/CT (p < 0.001). The proportion of lesions rated as non-pathological as a total of all PSMA-avid lesions detected for dPET/CT was comparable to aPET/CT (61.8% vs. 57.0%, p = 0.99). Neither a higher rate of diagnostically uncertain lesions (11.5% dPET/CT vs. 13.7% aPET/CT, p = 0.95) nor discrepant scans (where one or more readers differed in opinion as to whether the scan is pathological) were observed (18% dPET/CT vs. 17% aPET/CT, p = 0.76). Interrater reliability for pathological lesions was excellent for both scanner types (Cronbach’s α = 0.923 dPET/CT; α = 0.948 aPET/CT) and interrater agreement was substantial for dPET/CT (Krippendorf’s α = 0.701) and almost perfect in aPET/CT (α = 0.802). CONCLUSIONS: A higher detection rate for pathological lesions for dPET/CT compared with aPET/CT in multiple readers was observed. This improved sensitivity was coupled with an improved true-positive rate and was not associated with increased diagnostic uncertainty, rate of non-specific lesions, or reduced interrater reliability. KEY POINTS: • New generation digital scanners detect more cancer lesions in men with prostate cancer. • When using digital scanners, the doctors are able to diagnose prostate cancer lesions with better certainty • When using digital scanners, the doctors do not disagree with each other more than with other scanner types.
format Online
Article
Text
id pubmed-8452558
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-84525582021-10-05 The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer Alberts, Ian Hünermund, Jan-Niklas Sachpekidis, Christos Mingels, Clemens Fech, Viktor Bohn, Karl Peter Rominger, Axel Afshar-Oromieh, Ali Eur Radiol Nuclear Medicine OBJECTIVE: To investigate the impact of digital PET/CT on diagnostic certainty, patient-based sensitivity and interrater reliability. METHODS: Four physicians retrospectively evaluated two matched cohorts of patients undergoing [(68)Ga]Ga-PSMA-11 PET/CT on a digital (dPET/CT n = 65) or an analogue scanner (aPET/CT n = 65) for recurrent prostate cancer between 11/2018 and 03/2019. The number of equivocal and pathological lesions as well as the frequency of discrepant findings and the interrater reliability for the two scanners were compared. RESULTS: dPET/CT detected more lesions than aPET/CT (p < 0.001). A higher number of pathological scans were observed for dPET/CT (83% vs. 57%, p < 0.001). The true-positive rate at follow-up was 100% for dPET/CT compared to 84% for aPET/CT (p < 0.001). The proportion of lesions rated as non-pathological as a total of all PSMA-avid lesions detected for dPET/CT was comparable to aPET/CT (61.8% vs. 57.0%, p = 0.99). Neither a higher rate of diagnostically uncertain lesions (11.5% dPET/CT vs. 13.7% aPET/CT, p = 0.95) nor discrepant scans (where one or more readers differed in opinion as to whether the scan is pathological) were observed (18% dPET/CT vs. 17% aPET/CT, p = 0.76). Interrater reliability for pathological lesions was excellent for both scanner types (Cronbach’s α = 0.923 dPET/CT; α = 0.948 aPET/CT) and interrater agreement was substantial for dPET/CT (Krippendorf’s α = 0.701) and almost perfect in aPET/CT (α = 0.802). CONCLUSIONS: A higher detection rate for pathological lesions for dPET/CT compared with aPET/CT in multiple readers was observed. This improved sensitivity was coupled with an improved true-positive rate and was not associated with increased diagnostic uncertainty, rate of non-specific lesions, or reduced interrater reliability. KEY POINTS: • New generation digital scanners detect more cancer lesions in men with prostate cancer. • When using digital scanners, the doctors are able to diagnose prostate cancer lesions with better certainty • When using digital scanners, the doctors do not disagree with each other more than with other scanner types. Springer Berlin Heidelberg 2021-04-15 2021 /pmc/articles/PMC8452558/ /pubmed/33856522 http://dx.doi.org/10.1007/s00330-021-07870-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Nuclear Medicine
Alberts, Ian
Hünermund, Jan-Niklas
Sachpekidis, Christos
Mingels, Clemens
Fech, Viktor
Bohn, Karl Peter
Rominger, Axel
Afshar-Oromieh, Ali
The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
title The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
title_full The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
title_fullStr The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
title_full_unstemmed The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
title_short The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
title_sort influence of digital pet/ct on diagnostic certainty and interrater reliability in [(68)ga]ga-psma-11 pet/ct for recurrent prostate cancer
topic Nuclear Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452558/
https://www.ncbi.nlm.nih.gov/pubmed/33856522
http://dx.doi.org/10.1007/s00330-021-07870-5
work_keys_str_mv AT albertsian theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT hunermundjanniklas theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT sachpekidischristos theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT mingelsclemens theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT fechviktor theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT bohnkarlpeter theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT romingeraxel theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT afsharoromiehali theinfluenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT albertsian influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT hunermundjanniklas influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT sachpekidischristos influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT mingelsclemens influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT fechviktor influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT bohnkarlpeter influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT romingeraxel influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer
AT afsharoromiehali influenceofdigitalpetctondiagnosticcertaintyandinterraterreliabilityin68gagapsma11petctforrecurrentprostatecancer